Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Cannabis Oversight topic
No spam. Unsubscribe anytime.
Office of Cannabis reports equity progress; Rules Committee appoints three oversight‑committee members and continues the rest
Summary
At a Rules Committee hearing April 19, the Office of Cannabis told supervisors it had processed much of its equity application queue and provided tiered counts (167 tier‑1 equity applicants; 14 equity permits issued). The committee appointed Ali Jamalian (seat 8), Aaron Flynn (seat 9) and Jessica Scribe (seat 10) to the Cannabis Oversight Committee and continued the remaining selections to a follow‑up meeting.
Get email alerts on the Cannabis Oversight topic
No spam. Unsubscribe anytime.
The San Francisco Office of Cannabis briefed the Board of Supervisors Rules Committee on April 19, reporting that the city’s equity application queue has largely been processed and providing counts of applications and permits as the committee considered appointments to the Cannabis Oversight Committee.
Director Marissa Rodriguez and staff outlined the office’s priorities and capacity constraints, saying the office was "a small but mighty team of 7" handling a broad set of functions including equity verification, permitting, events and supply‑chain oversight. Ray Law, presenting slides, reported that the office had 167 tier‑1 (equity) applications in its system, with 40 close to permit issuance and 14 equity permits issued so far; staff said more permits were expected in the coming week.
The office described six applicant tiers and summarized activity across them: 25 incubator (tier‑2) applications; roughly 30 verified PENCO operators and three federally enforced MCDs among tier‑3; approximately 55 MCDs and 75 temporary permit holders in tier‑4; and 145 supply‑chain activities on file. The office also said the Cannabis Oversight Committee, created in December 2019, has 16 members (nine voting) and contracts with a third‑party administrator for neutral support.
Supervisors pressed staff on enforcement capacity. Rodriguez said the office is thinly staffed and focuses primarily on civil code enforcement in partnership with the City Attorney rather than criminal enforcement; the office handles complaints via 311 and an anonymous web intake and said resources constrain more aggressive action against the illicit market.
The hearing then moved through two‑minute remarks from dozens of applicants for the nine oversight‑committee seats. Applicants described backgrounds ranging from long involvement in the medical cannabis movement to recent experience as equity applicants, and prioritized issues such as technical assistance, workforce development, apprenticeship programs and better access to real estate and capital for verified equity operators.
During public comment, labor and legal organizations urged reappointments and highlighted candidates with experience supporting workers and offering pro bono legal help for equity applicants. John Gomez of UFCW Local 5 voiced support for Jessica Scribe; Carol Kahn, speaking for the Bar Association of San Francisco’s LRIS pro bono program, endorsed Josh Ridlis; other callers endorsed candidates including Reyna (Rayna) Jackson and Malcolm Josh Weitz.
After discussion about balancing incumbency, geographic residency and the desire to hear more candidates, Chair Aaron Peskin moved that the committee appoint Ali Jamalian to Seat 8, Aaron Flynn to Seat 9 and Jessica Scribe to Seat 10 and continue consideration of the remaining, more contested seats to the committee’s next meeting. The roll call recorded unanimous 'Aye' votes from Supervisors Mandelman, Chan and Peskin; the motion passed without objection.
The committee’s action advanced three appointments while leaving the bulk of the nine seats to be decided at a future meeting so members could review more applications and consider term staggering and other procedural adjustments.
The Rules Committee adjourned after taking those votes. The committee said it would resume consideration of the remaining Cannabis Oversight Committee seats at the follow‑up meeting it scheduled for next week at 10 a.m.
